bulk vaccine

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

South Korean beauty device manufacturers are aggressively pursuing mergers and acquisitions both at home and abroad to expand their scale, diversify...

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

South Korea's LX Pantos said on Thursday that it signed a joint venture (JV) agreement with KSA, Indonesia's largest bulk carrier, to tap into the S...

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Hanjin KAL Corp., the holding firm of South Korean flag carrier Korean Air Lines Co., is set to sell a 100% stake in its Hawaii-based subsidiary Wai...

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

HMM Co., South Korea’s top shipping company, is expanding its fleet, especially bulk carriers, for stable profits amid the sluggishness of the...

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

South Korean bulk carrier operator Polaris Shipping Co. is poised to sell its entire stake at around 600 billion won ($447.5 million) to Woori Priva...

Samsung C&T Renewables, the renewable energy corporation of South Korea's Samsung C&T Corp. in the US, announced on Thursday that it has s...

Hyundai Glovis Co., the logistics unit of South Korea's Hyundai Motor Group, announced on Wednesday that it will be a participant in Breakbulk Ameri...

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...

South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...